Exact Mass: 970.8805284

Exact Mass Matches: 970.8805284

Found 500 metabolites which its exact mass value is equals to given mass value 970.8805284, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dolichol-14

(2E,6E,10E,14E,18E,22E,26E,30E,34E,38E,42E,46E,50E)-3,7,11,15,19,23,27,31,35,39,43,47,51,55-tetradecamethylhexapentaconta-2,6,10,14,18,22,26,30,34,38,42,46,50,54-tetradecaen-1-ol

C70H114O (970.8869194)


Dolichols are polyisoprenic molecule ubiquitously present in the lipid fraction of animal and plant tissues, discovered 40 years ago during experiments on the biosynthesis of ubiquinone. The molecular structure of dolichol comprises a sequence of unsaturated isoprenic units bearing a primary terminal hydroxyl group. The length of dolichyl chains depends on the species of the organism from which they are isolated. Mammalian dolichol generally is made up of 16 to 23 unsaturated isoprene units, and the terminal hydroxyl group may exist either free or esterified with fatty acids, phosphoric acid, and pyrophosphoric acid. In biological membranes, this linear polyisoprenoid compound may be located between the two leaflets of the lipid bilayer, close to the free end of the phospholipid fatty acid molecules. Metabolism and function of dolichol were largely unknown until recently. Synthesis of dolichol by the mevalonate pathway was demonstrated in vitro and in vivo in many tissues. The isoprenoid pyrophosphate intermediates are shared by the cholesterol, dolichol, and ubiquinone pathways, and treatment with drugs that block hydroxymethyl glutaryl coenzyme A reductase may significantly decrease their plasma and tissue levels. In humans, there is no apparent positive correlation between serum dolichol and tissue dolichol and age. In view of the total content of the body, half-life of the total body dolichol, and dolichol content in the extracellular space, it was concluded that the dolichol in tissues probably derives from biosynthesis in those tissues and that relocation of dolichol via circulation cannot be prominent in vivo. The levels of dolichol in human serum have apparently no correlation to age or serum total cholesterol, and exhibit a linear correlation to high-density lipoprotein cholesterols which may reflect the fact that the dolichols are associated with the high-density lipoprotein fraction. No enzymic pathways for dolichol degradation were described, but no case of dolichol-storage disease was reported. Shrinkage of tissue because of increased lysosomal degradation in the process of atrophy does not affect the dolichol content and concentration increases. Small quantities of dolichol that may be excreted into the urine at least in part is derived from the lysosomes of the excretory organ, and serum dolichol levels may be elevated in chronic cholestatic liver diseases. Recent evidence shows that phagocytosis may cause the degradation and disposal of the engulfed dolichol, possibly because of nonenzymatic free radical mediated decomposition. By means of a 1H-nuclear magnetic resonance (NMR) analytical method, the hypothesis was substantiated that dolichol may act as a free-radical scavenger in the cell membranes and protect polyunsaturated fatty acids from peroxidation, and that it may undergo decomposition in the process. (PMID 15741281) [HMDB] Dolichols are polyisoprenic molecule ubiquitously present in the lipid fraction of animal and plant tissues, discovered 40 years ago during experiments on the biosynthesis of ubiquinone. The molecular structure of dolichol comprises a sequence of unsaturated isoprenic units bearing a primary terminal hydroxyl group. The length of dolichyl chains depends on the species of the organism from which they are isolated. Mammalian dolichol generally is made up of 16 to 23 unsaturated isoprene units, and the terminal hydroxyl group may exist either free or esterified with fatty acids, phosphoric acid, and pyrophosphoric acid. In biological membranes, this linear polyisoprenoid compound may be located between the two leaflets of the lipid bilayer, close to the free end of the phospholipid fatty acid molecules. Metabolism and function of dolichol were largely unknown until recently. Synthesis of dolichol by the mevalonate pathway was demonstrated in vitro and in vivo in many tissues. The isoprenoid pyrophosphate intermediates are shared by the cholesterol, dolichol, and ubiquinone pathways, and treatment with drugs that block hydroxymethyl glutaryl coenzyme A reductase may significantly decrease their plasma and tissue levels. In humans, there is no apparent positive correlation between serum dolichol and tissue dolichol and age. In view of the total content of the body, half-life of the total body dolichol, and dolichol content in the extracellular space, it was concluded that the dolichol in tissues probably derives from biosynthesis in those tissues and that relocation of dolichol via circulation cannot be prominent in vivo. The levels of dolichol in human serum have apparently no correlation to age or serum total cholesterol, and exhibit a linear correlation to high-density lipoprotein cholesterols which may reflect the fact that the dolichols are associated with the high-density lipoprotein fraction. No enzymic pathways for dolichol degradation were described, but no case of dolichol-storage disease was reported. Shrinkage of tissue because of increased lysosomal degradation in the process of atrophy does not affect the dolichol content and concentration increases. Small quantities of dolichol that may be excreted into the urine at least in part is derived from the lysosomes of the excretory organ, and serum dolichol levels may be elevated in chronic cholestatic liver diseases. Recent evidence shows that phagocytosis may cause the degradation and disposal of the engulfed dolichol, possibly because of nonenzymatic free radical mediated decomposition. By means of a 1H-nuclear magnetic resonance (NMR) analytical method, the hypothesis was substantiated that dolichol may act as a free-radical scavenger in the cell membranes and protect polyunsaturated fatty acids from peroxidation, and that it may undergo decomposition in the process. (PMID 15741281).

   

TG(20:0/20:1(11Z)/20:1(11Z))

(2S)-1-[(11Z)-icos-11-enoyloxy]-3-(icosanoyloxy)propan-2-yl (11Z)-icos-11-enoate

C63H118O6 (970.8927928)


TG(20:0/20:1(11Z)/20:1(11Z))[iso3] is a dieicosenoic acid triglyceride. Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/20:1(11Z)/20:1(11Z))[iso3], in particular, consists of one chain of arachidic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols. TG(20:0/20:1(11Z)/20:1(11Z))[iso3] is a dieicosenoic acid triglyceride. Triglycerides (TGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid tri-esters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/20:1(11Z)/20:1(11Z))[iso3], in particular, consists of one chain of arachidic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)

   

TG(14:0/24:0/22:2(13Z,16Z))

(2S)-1-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-(tetradecanoyloxy)propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(14:0/24:0/22:2(13Z,16Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/24:0/22:2(13Z,16Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(14:0/22:1(13Z)/24:1(15Z))

(2S)-2-[(13Z)-docos-13-enoyloxy]-3-(tetradecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(14:0/22:1(13Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/22:1(13Z)/24:1(15Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(14:0/24:1(15Z)/22:1(13Z))

(2S)-1-[(13Z)-docos-13-enoyloxy]-3-(tetradecanoyloxy)propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(14:0/24:1(15Z)/22:1(13Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/24:1(15Z)/22:1(13Z)), in particular, consists of one chain of myristic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(14:0/22:2(13Z,16Z)/24:0)

(2S)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-(tetradecanoyloxy)propyl tetracosanoate

C63H118O6 (970.8927928)


TG(14:0/22:2(13Z,16Z)/24:0) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:0/22:2(13Z,16Z)/24:0), in particular, consists of one chain of myristic acid at the C-1 position, one chain of docosadienoic acid at the C-2 position and one chain of lignoceric acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/22:0/22:2(13Z,16Z))

(2S)-2-(docosanoyloxy)-3-(hexadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(16:0/22:0/22:2(13Z,16Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/22:0/22:2(13Z,16Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/24:0/20:2n6)

(2S)-1-(hexadecanoyloxy)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(16:0/24:0/20:2n6) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/24:0/20:2n6), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/20:1(11Z)/24:1(15Z))

(2S)-3-(hexadecanoyloxy)-2-[(11Z)-icos-11-enoyloxy]propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(16:0/20:1(11Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/20:1(11Z)/24:1(15Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/22:1(13Z)/22:1(13Z))

(2S)-1-[(13Z)-docos-13-enoyloxy]-3-(hexadecanoyloxy)propan-2-yl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(16:0/22:1(13Z)/22:1(13Z)) is a dierucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/22:1(13Z)/22:1(13Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/24:1(15Z)/20:1(11Z))

(2S)-1-(hexadecanoyloxy)-3-[(11Z)-icos-11-enoyloxy]propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(16:0/24:1(15Z)/20:1(11Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/24:1(15Z)/20:1(11Z)), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/20:2n6/24:0)

(2S)-3-(hexadecanoyloxy)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(16:0/20:2n6/24:0) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/20:2n6/24:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of lignoceric acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:0/22:2(13Z,16Z)/22:0)

(2S)-1-(docosanoyloxy)-3-(hexadecanoyloxy)propan-2-yl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(16:0/22:2(13Z,16Z)/22:0) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:0/22:2(13Z,16Z)/22:0), in particular, consists of one chain of palmitic acid at the C-1 position, one chain of docosadienoic acid at the C-2 position and one chain of behenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/20:0/22:2(13Z,16Z))

(2S)-2-(icosanoyloxy)-3-(octadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(18:0/20:0/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/20:0/22:2(13Z,16Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/22:0/20:2n6)

(2S)-1-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-(octadecanoyloxy)propan-2-yl docosanoate

C63H118O6 (970.8927928)


TG(18:0/22:0/20:2n6) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/22:0/20:2n6), in particular, consists of one chain of stearic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/24:0/18:2(9Z,12Z))

(2S)-1-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(octadecanoyloxy)propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(18:0/24:0/18:2(9Z,12Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/24:0/18:2(9Z,12Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/18:1(11Z)/24:1(15Z))

(2S)-2-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:0/18:1(11Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/18:1(11Z)/24:1(15Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/18:1(9Z)/24:1(15Z))

(2S)-2-[(9Z)-octadec-9-enoyloxy]-3-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:0/18:1(9Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/18:1(9Z)/24:1(15Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/20:1(11Z)/22:1(13Z))

(2S)-2-[(11Z)-icos-11-enoyloxy]-3-(octadecanoyloxy)propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(18:0/20:1(11Z)/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/20:1(11Z)/22:1(13Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/22:1(13Z)/20:1(11Z))

(2S)-1-[(11Z)-icos-11-enoyloxy]-3-(octadecanoyloxy)propan-2-yl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(18:0/22:1(13Z)/20:1(11Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/22:1(13Z)/20:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/24:1(15Z)/18:1(11Z))

(2S)-1-[(11Z)-octadec-11-enoyloxy]-3-(octadecanoyloxy)propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:0/24:1(15Z)/18:1(11Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/24:1(15Z)/18:1(11Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/24:1(15Z)/18:1(9Z))

(2S)-1-[(9Z)-octadec-9-enoyloxy]-3-(octadecanoyloxy)propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:0/24:1(15Z)/18:1(9Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/24:1(15Z)/18:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/18:2(9Z,12Z)/24:0)

(2S)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(octadecanoyloxy)propyl tetracosanoate

C63H118O6 (970.8927928)


TG(18:0/18:2(9Z,12Z)/24:0) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/18:2(9Z,12Z)/24:0), in particular, consists of one chain of stearic acid at the C-1 position, one chain of linoleic acid at the C-2 position and one chain of lignoceric acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/20:2n6/22:0)

(2S)-2-[(11Z,14Z)-icosa-11,14-dienoyloxy]-3-(octadecanoyloxy)propyl docosanoate

C63H118O6 (970.8927928)


TG(18:0/20:2n6/22:0) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/20:2n6/22:0), in particular, consists of one chain of stearic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of behenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:0/22:2(13Z,16Z)/20:0)

(2S)-1-(icosanoyloxy)-3-(octadecanoyloxy)propan-2-yl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(18:0/22:2(13Z,16Z)/20:0) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:0/22:2(13Z,16Z)/20:0), in particular, consists of one chain of stearic acid at the C-1 position, one chain of docosadienoic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/18:0/22:2(13Z,16Z))

(2S)-3-(icosanoyloxy)-2-(octadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(20:0/18:0/22:2(13Z,16Z)) is a monodocosadienoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/18:0/22:2(13Z,16Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/20:0/20:2n6)

(2S)-2,3-bis(icosanoyloxy)propyl (11Z,14Z)-icosa-11,14-dienoate

C63H118O6 (970.8927928)


TG(20:0/20:0/20:2n6) is a diarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/20:0/20:2n6), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/22:0/18:2(9Z,12Z))

(2S)-1-(icosanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propan-2-yl docosanoate

C63H118O6 (970.8927928)


TG(20:0/22:0/18:2(9Z,12Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/22:0/18:2(9Z,12Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/16:1(9Z)/24:1(15Z))

(2S)-2-[(9Z)-hexadec-9-enoyloxy]-3-(icosanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(20:0/16:1(9Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/16:1(9Z)/24:1(15Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/18:1(11Z)/22:1(13Z))

(2S)-3-(icosanoyloxy)-2-[(11Z)-octadec-11-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(20:0/18:1(11Z)/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/18:1(11Z)/22:1(13Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/18:1(9Z)/22:1(13Z))

(2S)-3-(icosanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(20:0/18:1(9Z)/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/18:1(9Z)/22:1(13Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/22:1(13Z)/18:1(11Z))

(2S)-1-(icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propan-2-yl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(20:0/22:1(13Z)/18:1(11Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/22:1(13Z)/18:1(11Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/22:1(13Z)/18:1(9Z))

(2S)-1-(icosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propan-2-yl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(20:0/22:1(13Z)/18:1(9Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/22:1(13Z)/18:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/24:1(15Z)/16:1(9Z))

(2S)-1-[(9Z)-hexadec-9-enoyloxy]-3-(icosanoyloxy)propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(20:0/24:1(15Z)/16:1(9Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/24:1(15Z)/16:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/18:2(9Z,12Z)/22:0)

(2S)-3-(icosanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(20:0/18:2(9Z,12Z)/22:0) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/18:2(9Z,12Z)/22:0), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of linoleic acid at the C-2 position and one chain of behenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:0/20:2n6/20:0)

1,3-bis(icosanoyloxy)propan-2-yl (11Z,14Z)-icosa-11,14-dienoate

C63H118O6 (970.8927928)


TG(20:0/20:2n6/20:0) is a diarachidic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:0/20:2n6/20:0), in particular, consists of one chain of arachidic acid at the C-1 position, one chain of eicosadienoic acid at the C-2 position and one chain of arachidic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/16:0/22:2(13Z,16Z))

(2S)-3-(docosanoyloxy)-2-(hexadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


TG(22:0/16:0/22:2(13Z,16Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/16:0/22:2(13Z,16Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/18:0/20:2n6)

(2S)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]-2-(octadecanoyloxy)propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/18:0/20:2n6) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/18:0/20:2n6), in particular, consists of one chain of behenic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/20:0/18:2(9Z,12Z))

(2S)-2-(icosanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/20:0/18:2(9Z,12Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/20:0/18:2(9Z,12Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/14:1(9Z)/24:1(15Z))

(2S)-3-(docosanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(22:0/14:1(9Z)/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/14:1(9Z)/24:1(15Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/16:1(9Z)/22:1(13Z))

(2S)-3-(docosanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(22:0/16:1(9Z)/22:1(13Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/16:1(9Z)/22:1(13Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/18:1(11Z)/20:1(11Z))

(2S)-3-[(11Z)-icos-11-enoyloxy]-2-[(11Z)-octadec-11-enoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/18:1(11Z)/20:1(11Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/18:1(11Z)/20:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/18:1(9Z)/20:1(11Z))

(2S)-3-[(11Z)-icos-11-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/18:1(9Z)/20:1(11Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/18:1(9Z)/20:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/20:1(11Z)/18:1(11Z))

(2S)-2-[(11Z)-icos-11-enoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/20:1(11Z)/18:1(11Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/20:1(11Z)/18:1(11Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/20:1(11Z)/18:1(9Z))

(2S)-2-[(11Z)-icos-11-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propyl docosanoate

C63H118O6 (970.8927928)


TG(22:0/20:1(11Z)/18:1(9Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/20:1(11Z)/18:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/22:1(13Z)/16:1(9Z))

(2S)-1-(docosanoyloxy)-3-[(9Z)-hexadec-9-enoyloxy]propan-2-yl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(22:0/22:1(13Z)/16:1(9Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/22:1(13Z)/16:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:0/24:1(15Z)/14:1(9Z))

(2S)-1-(docosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(22:0/24:1(15Z)/14:1(9Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:0/24:1(15Z)/14:1(9Z)), in particular, consists of one chain of behenic acid at the C-1 position, one chain of nervonic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/14:0/22:2(13Z,16Z))

(2S)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-(tetradecanoyloxy)propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/14:0/22:2(13Z,16Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/14:0/22:2(13Z,16Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of docosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/16:0/20:2n6)

(2S)-2-(hexadecanoyloxy)-3-[(11Z,14Z)-icosa-11,14-dienoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/16:0/20:2n6) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/16:0/20:2n6), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of eicosadienoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/18:0/18:2(9Z,12Z))

(2S)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-2-(octadecanoyloxy)propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/18:0/18:2(9Z,12Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/18:0/18:2(9Z,12Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of linoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/14:1(9Z)/22:1(13Z))

(2S)-3-[(13Z)-docos-13-enoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/14:1(9Z)/22:1(13Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/14:1(9Z)/22:1(13Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of myristoleic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/16:1(9Z)/20:1(11Z))

(2S)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(11Z)-icos-11-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/16:1(9Z)/20:1(11Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/16:1(9Z)/20:1(11Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of palmitoleic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/18:1(11Z)/18:1(11Z))

1-Tetracosanoyl-2-(11Z-octadecenoyl)-3-(11Z-octadecenoyl)-glycerol

C63H118O6 (970.8927928)


TG(24:0/18:1(11Z)/18:1(11Z)) is a divaccenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/18:1(11Z)/18:1(11Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/18:1(11Z)/18:1(9Z))

(2S)-2-[(11Z)-octadec-11-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/18:1(11Z)/18:1(9Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/18:1(11Z)/18:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of vaccenic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/18:1(9Z)/18:1(11Z))

(2S)-3-[(11Z)-octadec-11-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/18:1(9Z)/18:1(11Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/18:1(9Z)/18:1(11Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/18:1(9Z)/18:1(9Z))

1-Tetracosanoyl-2-(9Z-octadecenoyl)-3-(9Z-octadecenoyl)-glycerol

C63H118O6 (970.8927928)


TG(24:0/18:1(9Z)/18:1(9Z)) is a dioleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/18:1(9Z)/18:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of oleic acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/20:1(11Z)/16:1(9Z))

(2S)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(11Z)-icos-11-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/20:1(11Z)/16:1(9Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/20:1(11Z)/16:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of eicosenoic acid at the C-2 position and one chain of palmitoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(24:0/22:1(13Z)/14:1(9Z))

(2S)-2-[(13Z)-docos-13-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propyl tetracosanoate

C63H118O6 (970.8927928)


TG(24:0/22:1(13Z)/14:1(9Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(24:0/22:1(13Z)/14:1(9Z)), in particular, consists of one chain of lignoceric acid at the C-1 position, one chain of erucic acid at the C-2 position and one chain of myristoleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(14:1(9Z)/22:0/24:1(15Z))

(2R)-2-(docosanoyloxy)-3-[(9Z)-tetradec-9-enoyloxy]propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(14:1(9Z)/22:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:1(9Z)/22:0/24:1(15Z)), in particular, consists of one chain of myristoleic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(14:1(9Z)/24:0/22:1(13Z))

(2R)-1-[(13Z)-docos-13-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(14:1(9Z)/24:0/22:1(13Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(14:1(9Z)/24:0/22:1(13Z)), in particular, consists of one chain of myristoleic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:1(9Z)/20:0/24:1(15Z))

(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-(icosanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(16:1(9Z)/20:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/20:0/24:1(15Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:1(9Z)/22:0/22:1(13Z))

(2R)-2-(docosanoyloxy)-3-[(9Z)-hexadec-9-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(16:1(9Z)/22:0/22:1(13Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/22:0/22:1(13Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:1(9Z)/24:0/20:1(11Z))

(2R)-1-[(9Z)-hexadec-9-enoyloxy]-3-[(11Z)-icos-11-enoyloxy]propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(16:1(9Z)/24:0/20:1(11Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(16:1(9Z)/24:0/20:1(11Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(11Z)/18:0/24:1(15Z))

(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:1(11Z)/18:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/18:0/24:1(15Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(11Z)/20:0/22:1(13Z))

(2R)-2-(icosanoyloxy)-3-[(11Z)-octadec-11-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(18:1(11Z)/20:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/20:0/22:1(13Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(11Z)/22:0/20:1(11Z))

(2S)-1-[(11Z)-icos-11-enoyloxy]-3-[(11Z)-octadec-11-enoyloxy]propan-2-yl docosanoate

C63H118O6 (970.8927928)


TG(18:1(11Z)/22:0/20:1(11Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/22:0/20:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(11Z)/24:0/18:1(11Z))

1-(11Z-Octadecenoyl)-2-tetracosanoyl-3-(11Z-octadecenoyl)-glycerol

C63H118O6 (970.8927928)


TG(18:1(11Z)/24:0/18:1(11Z)) is a divaccenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/24:0/18:1(11Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of vaccenic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(11Z)/24:0/18:1(9Z))

(2S)-1-[(11Z)-octadec-11-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propan-2-yl tetracosanoate

C63H118O6 (970.8927928)


TG(18:1(11Z)/24:0/18:1(9Z)) is a monolignoceric acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(11Z)/24:0/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(9Z)/18:0/24:1(15Z))

(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(octadecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(18:1(9Z)/18:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/18:0/24:1(15Z)), in particular, consists of one chain of oleic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(9Z)/20:0/22:1(13Z))

(2R)-2-(icosanoyloxy)-3-[(9Z)-octadec-9-enoyloxy]propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(18:1(9Z)/20:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/20:0/22:1(13Z)), in particular, consists of one chain of oleic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(9Z)/22:0/20:1(11Z))

(2R)-1-[(11Z)-icos-11-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propan-2-yl docosanoate

C63H118O6 (970.8927928)


TG(18:1(9Z)/22:0/20:1(11Z)) is a monobehenic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/22:0/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position, one chain of behenic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(18:1(9Z)/24:0/18:1(9Z))

1-(9Z-Octadecenoyl)-2-tetracosanoyl-3-(9Z-octadecenoyl)-glycerol

C63H118O6 (970.8927928)


TG(18:1(9Z)/24:0/18:1(9Z)) is a dioleic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(18:1(9Z)/24:0/18:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position, one chain of lignoceric acid at the C-2 position and one chain of oleic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:1(11Z)/16:0/24:1(15Z))

(2R)-2-(hexadecanoyloxy)-3-[(11Z)-icos-11-enoyloxy]propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(20:1(11Z)/16:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:1(11Z)/16:0/24:1(15Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:1(11Z)/18:0/22:1(13Z))

(2R)-3-[(11Z)-icos-11-enoyloxy]-2-(octadecanoyloxy)propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(20:1(11Z)/18:0/22:1(13Z)) is a monoerucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:1(11Z)/18:0/22:1(13Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position, one chain of stearic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(20:1(11Z)/20:0/20:1(11Z))

3-[(11Z)-icos-11-enoyloxy]-2-(icosanoyloxy)propyl (11Z)-icos-11-enoate

C63H118O6 (970.8927928)


TG(20:1(11Z)/20:0/20:1(11Z)) is a dieicosenoic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(20:1(11Z)/20:0/20:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position, one chain of arachidic acid at the C-2 position and one chain of eicosenoic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:1(13Z)/14:0/24:1(15Z))

(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(tetradecanoyloxy)propyl (15Z)-tetracos-15-enoate

C63H118O6 (970.8927928)


TG(22:1(13Z)/14:0/24:1(15Z)) is a mononervonic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:1(13Z)/14:0/24:1(15Z)), in particular, consists of one chain of erucic acid at the C-1 position, one chain of myristic acid at the C-2 position and one chain of nervonic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(22:1(13Z)/16:0/22:1(13Z))

3-[(13Z)-docos-13-enoyloxy]-2-(hexadecanoyloxy)propyl (13Z)-docos-13-enoate

C63H118O6 (970.8927928)


TG(22:1(13Z)/16:0/22:1(13Z)) is a dierucic acid triglyceride. Triglycerides (TGs or TAGs) are also known as triacylglycerols or triacylglycerides, meaning that they are glycerides in which the glycerol is esterified with three fatty acid groups (i.e. fatty acid trimesters of glycerol). TGs may be divided into three general types with respect to their acyl substituents. They are simple or monoacid if they contain only one type of fatty acid, diacid if they contain two types of fatty acids and triacid if three different acyl groups. Chain lengths of the fatty acids in naturally occurring triglycerides can be of varying lengths and saturations but 16, 18 and 20 carbons are the most common. TG(22:1(13Z)/16:0/22:1(13Z)), in particular, consists of one chain of erucic acid at the C-1 position, one chain of palmitic acid at the C-2 position and one chain of erucic acid at the C-3 position. TGs are the main constituent of vegetable oil and animal fats. TGs are major components of very low density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice the energy (9 kcal/g) of carbohydrates and proteins. In the intestine, triglycerides are split into glycerol and fatty acids (this process is called lipolysis) with the help of lipases and bile secretions, which can then move into blood vessels. The triglycerides are rebuilt in the blood from their fragments and become constituents of lipoproteins, which deliver the fatty acids to and from fat cells among other functions. Various tissues can release the free fatty acids and take them up as a source of energy. Fat cells can synthesize and store triglycerides. When the body requires fatty acids as an energy source, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipase to release free fatty acids. As the brain cannot utilize fatty acids as an energy source, the glycerol component of triglycerides can be converted into glucose for brain fuel when it is broken down. (www.cyberlipid.org, www.wikipedia.org)
TAGs can serve as fatty acid stores in all cells, but primarily in adipocytes of adipose tissue. The major building block for the synthesis of triacylglycerides, in non-adipose tissue, is glycerol. Adipocytes lack glycerol kinase and so must use another route to TAG synthesis. Specifically, dihydroxyacetone phosphate (DHAP), which is produced during glycolysis, is the precursor for TAG synthesis in adipose tissue. DHAP can also serve as a TAG precursor in non-adipose tissues, but does so to a much lesser extent than glycerol. The use of DHAP for the TAG backbone depends on whether the synthesis of the TAGs occurs in the mitochondria and ER or the ER and the peroxisomes. The ER/mitochondria pathway requires the action of glycerol-3-phosphate dehydrogenase to convert DHAP to glycerol-3-phosphate. Glycerol-3-phosphate acyltransferase then esterifies a fatty acid to glycerol-3-phosphate thereby generating lysophosphatidic acid. The ER/peroxisome reaction pathway uses the peroxisomal enzyme DHAP acyltransferase to acylate DHAP to acyl-DHAP which is then reduced by acyl-DHAP reductase. The fatty acids that are incorporated into TAGs are activated to acyl-CoAs through the action of acyl-CoA synthetases. Two molecules of acyl-CoA are esterified to glycerol-3-phosphate to yield 1,2-diacylglycerol phosphate (also known as phosphatidic acid). The phosphate is then removed by phosphatidic acid phosphatase (PAP1), to generate 1,2-diacylglycerol. This diacylglycerol serves as the substrate for addition of the third fatty acid to make TAG. Intestinal monoacylglycerols, derived from dietary fats, can also serve as substrates for the synthesis of 1,2-diacylglycerols.

   

TG(16:1(9Z)/22:0/22:1(11Z))[iso6]

1-(9Z-hexadecenoyl)-2-docosanoyl-3-11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(17:1(9Z)/21:0/22:1(11Z))[iso6]

1-(9Z-heptadecenoyl)-2-heneicosanoyl-3-11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:0/20:1(11Z)/22:1(11Z))[iso6]

1-octadecanoyl-2-(11Z-eicosenoyl)-3-11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:1(9Z)/20:0/22:1(11Z))[iso6]

1-(9Z-octadecenoyl)-2-eicosanoyl-3-11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(19:0/19:1(9Z)/22:1(11Z))[iso6]

1-nonadecanoyl-2-9Z-nonadecenoyl-3-11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(20:0/20:1/20:1)[iso3]

1-eicosanoyl-2,3-di-(11Z-eicosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(20:0/20:0/20:2)[iso3]

1,2-dieicosanoyl-3-(11Z,14Z-eicosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:0/20:2/22:0)[iso6]

1-octadecanoyl-2-(11Z,14Z-eicosadienoyl)-3-docosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:1/20:1/22:0)[iso6]

1-(9Z-octadecenoyl)-2-(11Z-eicosenoyl)-3-docosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:2/20:0/22:0)[iso6]

1-(9Z,12Z-octadecadienoyl)-2-eicosanoyl-3-docosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:0/20:1/22:1)[iso6]

1-octadecanoyl-2-(11Z-eicosenoyl)-3-(13Z-docosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:1/20:0/22:1)[iso6]

1-(9Z-octadecenoyl)-2-eicosanoyl-3-(13Z-docosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:0/20:0/22:2)[iso6]

1-octadecanoyl-2-eicosanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(16:0/22:1/22:1)[iso3]

1-hexadecanoyl-2,3-di-(13Z-docosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(16:1/22:0/22:1)[iso6]

1-(9Z-hexadecenoyl)-2-docosanoyl-3-(13Z-docosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(19:0/20:2/21:0)[iso6]

1-nonadecanoyl-2-(11Z,14Z-eicosadienoyl)-3-heneicosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(17:2/21:0/22:0)[iso6]

1-(9Z,12Z-heptadecadienoyl)-2-heneicosanoyl-3-docosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG(17:1/21:0/22:1)[iso6]

1-(9Z-heptadecenoyl)-2-heneicosanoyl-3-(13Z-docosenoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(16:0/22:0/22:2)[iso6]

1-hexadecanoyl-2-docosanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(17:0/21:0/22:2)[iso6]

1-heptadecanoyl-2-heneicosanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(19:0/19:0/22:2)[iso3]

1,2-dinonadecanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

TG(18:2/21:0/21:0)[iso3]

1-(9Z,12Z-octadecadienoyl)-2,3-diheneicosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

1-hexadecanoyl-2,3-di11Z-docosenoyl-sn-glycerol

1-hexadecanoyl-2,3-di11Z-docosenoyl-sn-glycerol

C63H118O6 (970.8927928)


   

1,2-di9Z-nonadecenoyl-3-docosanoyl-sn-glycerol

1,2-di9Z-nonadecenoyl-3-docosanoyl-sn-glycerol

C63H118O6 (970.8927928)


   

TG 60:2

1-heptadecanoyl-2-heneicosanoyl-3-(13Z,16Z-docosadienoyl)-sn-glycerol

C63H118O6 (970.8927928)


   

tetracosanoic acid, 2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]-1-[[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]methyl]ethyl ester

tetracosanoic acid, 2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]-1-[[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]methyl]ethyl ester

C63H118O6 (970.8927928)


   

1-Myristoyl-2-docosadienoyl-3-lignoceroyl-glycerol

1-Myristoyl-2-docosadienoyl-3-lignoceroyl-glycerol

C63H118O6 (970.8927928)


   

1-Stearoyl-2-lignoceroyl-3-linoleoyl-glycerol

1-Stearoyl-2-lignoceroyl-3-linoleoyl-glycerol

C63H118O6 (970.8927928)


   

1-Behenoyl-2-erucoyl-3-palmitoleoyl-glycerol

1-Behenoyl-2-erucoyl-3-palmitoleoyl-glycerol

C63H118O6 (970.8927928)


   

1-Lignoceroyl-2-palmitoyl-3-eicosadienoyl-glycerol

1-Lignoceroyl-2-palmitoyl-3-eicosadienoyl-glycerol

C63H118O6 (970.8927928)


   

1-Arachidonyl-2-eicosenoyl-3-eicosenoyl-glycerol

1-Arachidonyl-2-eicosenoyl-3-eicosenoyl-glycerol

C63H118O6 (970.8927928)


   

[2-(Hexadecanoylamino)-3-hydroxyheptatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexadecanoylamino)-3-hydroxyheptatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tritetracontanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tritetracontanoylamino)decyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Dotetracontanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Dotetracontanoylamino)-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Heptadecanoylamino)-3-hydroxyhexatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptadecanoylamino)-3-hydroxyhexatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(pentadecanoylamino)octatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentadecanoylamino)octatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tetracontanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tetracontanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Docosanoylamino)-3-hydroxyhentriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Docosanoylamino)-3-hydroxyhentriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(icosanoylamino)tritriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(icosanoylamino)tritriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Henicosanoylamino)-3-hydroxydotriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Henicosanoylamino)-3-hydroxydotriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Hentetracontanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hentetracontanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(nonadecanoylamino)tetratriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonadecanoylamino)tetratriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Heptatriacontanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptatriacontanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(nonatriacontanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonatriacontanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(octadecanoylamino)pentatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octadecanoylamino)pentatriacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

(3-nonanoyloxy-2-pentadecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

(3-nonanoyloxy-2-pentadecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

C63H118O6 (970.8927928)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-octanoyloxypropan-2-yl] hexacosanoate

[1-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxy-3-octanoyloxypropan-2-yl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] triacontanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

(3-nonanoyloxy-2-tridecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

(3-nonanoyloxy-2-tridecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-hexatriacont-25-enoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-hexatriacont-25-enoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-octanoyloxypropyl] triacontanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-octanoyloxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

(2-octadecanoyloxy-3-octanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

(2-octadecanoyloxy-3-octanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

(3-nonanoyloxy-2-pentacosanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(3-nonanoyloxy-2-pentacosanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

(3-octanoyloxy-2-tetracosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(3-octanoyloxy-2-tetracosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[3-nonanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] heptacosanoate

[3-nonanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[3-octanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-octacos-17-enoate

[3-octanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[3-octanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] octacosanoate

[3-octanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] pentatriacontanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] pentatriacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-nonanoyloxypropyl] (Z)-triacont-19-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-nonanoyloxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] hentriacontanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

(3-octanoyloxy-2-tetradecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

(3-octanoyloxy-2-tetradecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-nonanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(2-henicosanoyloxy-3-nonanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-octanoyloxypropyl] (Z)-dotriacont-21-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-octanoyloxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

(2-hexadecanoyloxy-3-octanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

(2-hexadecanoyloxy-3-octanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

C63H118O6 (970.8927928)


   

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-octatriacont-27-enoate

[3-octanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-octatriacont-27-enoate

C63H118O6 (970.8927928)


   

(2-heptadecanoyloxy-3-nonanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

(2-heptadecanoyloxy-3-nonanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] pentatriacontanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] pentatriacontanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] dotriacontanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-octanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(2-icosanoyloxy-3-octanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-nonanoyloxypropyl] (Z)-tetratriacont-23-enoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-nonanoyloxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-octatriacont-27-enoate

[3-nonanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-octatriacont-27-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] dotriacontanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-tetratriacont-23-enoate

[2-[(Z)-octadec-9-enoyl]oxy-3-octanoyloxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-octanoyloxypropyl] (Z)-triacont-19-enoate

[2-[(Z)-docos-13-enoyl]oxy-3-octanoyloxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-nonanoyloxypropyl] (Z)-dotriacont-21-enoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-nonanoyloxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

(2-docosanoyloxy-3-octanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(2-docosanoyloxy-3-octanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-hexatriacont-25-enoate

[3-nonanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-hexatriacont-25-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] tritriacontanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] tritriacontanoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-nonanoyloxypropyl] nonacosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-nonanoyloxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] hentriacontanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonanoyloxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] hexatriacontanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] hexatriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] tetratriacontanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] tetratriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] tetratriacontanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octanoyloxypropyl] tetratriacontanoate

C63H118O6 (970.8927928)


   

[3-nonanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tritriacontanoate

[3-nonanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tritriacontanoate

C63H118O6 (970.8927928)


   

(3-nonanoyloxy-2-tricosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(3-nonanoyloxy-2-tricosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropyl] (Z)-hexacos-15-enoate

[2-[(Z)-hexacos-15-enoyl]oxy-3-octanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

(2-nonadecanoyloxy-3-nonanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(2-nonadecanoyloxy-3-nonanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl tetracosanoate

2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] (Z)-docos-13-enoate

[2-[(Z)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[1-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

[1-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

[1-[(Z)-docos-13-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] docosanoate

[1-[(Z)-docos-13-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-octadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

(2-icosanoyloxy-3-octadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

[2-icosanoyloxy-3-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-docos-13-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] docosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] tetracosanoate

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tetradecanoyloxypropyl] tetracosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tetradecanoyloxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] tetracosanoate

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecanoyloxypropyl] heptacosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-undecanoyloxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

(2-docosanoyloxy-3-dodecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(2-docosanoyloxy-3-dodecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-octacos-17-enoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-undecanoyloxypropyl] nonacosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-undecanoyloxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-hexacos-15-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-tricosanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[2-tricosanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

(3-dodecanoyloxy-2-icosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(3-dodecanoyloxy-2-icosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-dodecanoyloxypropyl] hexacosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-dodecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

(3-dodecanoyloxy-2-octadecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(3-dodecanoyloxy-2-octadecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

[3-decanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] dotriacontanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] hentriacontanoate

[3-decanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] hentriacontanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

(3-dodecanoyloxy-2-hexadecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(3-dodecanoyloxy-2-hexadecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

(2-nonadecanoyloxy-3-undecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(2-nonadecanoyloxy-3-undecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[2-icosanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-tetratriacont-23-enoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] dotriacontanoate

[3-decanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] octacosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

(2-hexadecanoyloxy-3-tetradecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(2-hexadecanoyloxy-3-tetradecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] triacontanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-hexacos-15-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] nonacosanoate

[3-decanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

[3-decanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] hexacosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-heptadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

[2-heptadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-dodecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

(3-decanoyloxy-2-dodecanoyloxypropyl) (27Z,30Z)-octatriaconta-27,30-dienoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-undecanoyloxypropyl] octacosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-undecanoyloxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

2,3-di(dodecanoyloxy)propyl (25Z,28Z)-hexatriaconta-25,28-dienoate

2,3-di(dodecanoyloxy)propyl (25Z,28Z)-hexatriaconta-25,28-dienoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tridecanoyloxypropyl] pentacosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-tridecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-tridec-9-enoyl]oxy]propyl tetratriacontanoate

2,3-bis[[(Z)-tridec-9-enoyl]oxy]propyl tetratriacontanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] tetratriacontanoate

[3-decanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] tetratriacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] tritriacontanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] tritriacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-dotriacont-21-enoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] triacontanoate

[3-decanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[2-henicosanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] dotriacontanoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-hexatriacont-25-enoate

[2-[(Z)-tridec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-hexatriacont-25-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] (Z)-octacos-17-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-octacos-17-enoate

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[3-tetradecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

[3-tetradecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

(2-docosanoyloxy-3-tetradecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

(2-docosanoyloxy-3-tetradecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] heptacosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-triacont-19-enoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

2,3-di(undecanoyloxy)propyl (27Z,30Z)-octatriaconta-27,30-dienoate

2,3-di(undecanoyloxy)propyl (27Z,30Z)-octatriaconta-27,30-dienoate

C63H118O6 (970.8927928)


   

(2-pentadecanoyloxy-3-undecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

(2-pentadecanoyloxy-3-undecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] pentacosanoate

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] hentriacontanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-undecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(2-henicosanoyloxy-3-undecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] pentacosanoate

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-tetracosanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(3-decanoyloxy-2-tetracosanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] tritriacontanoate

[3-decanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] tritriacontanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[3-decanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-dotriacont-21-enoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-tridecanoyloxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] hentriacontanoate

[3-dodecanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

[3-dodecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[3-tridecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

[3-tridecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-tetratriacont-23-enoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-hexatriacont-25-enoate

[3-decanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-hexatriacont-25-enoate

C63H118O6 (970.8927928)


   

(2-tridecanoyloxy-3-undecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

(2-tridecanoyloxy-3-undecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-triacont-19-enoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tridecanoyloxypropyl] hexacosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tridecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-hexadecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

(3-decanoyloxy-2-hexadecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] heptacosanoate

[3-dodecanoyloxy-2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-triacont-19-enoate

[3-decanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(Z)-docos-13-enoyl]oxypropyl] (Z)-octacos-17-enoate

[3-decanoyloxy-2-[(Z)-docos-13-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-tetradecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(2-icosanoyloxy-3-tetradecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

2,3-di(tridecanoyloxy)propyl (23Z,26Z)-tetratriaconta-23,26-dienoate

2,3-di(tridecanoyloxy)propyl (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

[3-dodecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] hexacosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] nonacosanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-octadecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(3-decanoyloxy-2-octadecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[3-dodecanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

(2-tricosanoyloxy-3-tridecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

(2-tricosanoyloxy-3-tridecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-pentadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

[2-pentadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

(2-pentadecanoyloxy-3-tridecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(2-pentadecanoyloxy-3-tridecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] pentacosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-tetradecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

(2-nonadecanoyloxy-3-tridecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(2-nonadecanoyloxy-3-tridecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[2-nonadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

[2-nonadecanoyloxy-3-[(Z)-tridec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-tridecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(2-henicosanoyloxy-3-tridecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] hentriacontanoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

[1-dodecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropan-2-yl] tetracosanoate

[1-dodecanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropan-2-yl] tetracosanoate

C63H118O6 (970.8927928)


   

2,3-di(tetradecanoyloxy)propyl (21Z,24Z)-dotriaconta-21,24-dienoate

2,3-di(tetradecanoyloxy)propyl (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] nonacosanoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] octacosanoate

[3-decanoyloxy-2-[(13Z,16Z)-docosa-13,16-dienoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] hexacosanoate

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] (Z)-hexacos-15-enoate

[2-[(Z)-docos-13-enoyl]oxy-3-dodecanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] triacontanoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-docosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(3-decanoyloxy-2-docosanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[2-docosanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[2-docosanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-tetradecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

(3-decanoyloxy-2-tetradecanoyloxypropyl) (25Z,28Z)-hexatriaconta-25,28-dienoate

C63H118O6 (970.8927928)


   

(2-heptadecanoyloxy-3-tridecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(2-heptadecanoyloxy-3-tridecanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] hentriacontanoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] hentriacontanoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-undecanoyloxypropyl] pentacosanoate

[2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxy-3-undecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-triacont-19-enoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-undecanoyloxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] nonacosanoate

[3-dodecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] dotriacontanoate

[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] dotriacontanoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

[3-dodecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-dotriacont-21-enoate

C63H118O6 (970.8927928)


   

(2-heptadecanoyloxy-3-undecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

(2-heptadecanoyloxy-3-undecanoyloxypropyl) (21Z,24Z)-dotriaconta-21,24-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tritriacontanoate

[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] tritriacontanoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] octacosanoate

[3-dodecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

(3-dodecanoyloxy-2-tetradecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

(3-dodecanoyloxy-2-tetradecanoyloxypropyl) (23Z,26Z)-tetratriaconta-23,26-dienoate

C63H118O6 (970.8927928)


   

(2-tricosanoyloxy-3-undecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(2-tricosanoyloxy-3-undecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] nonacosanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tridecanoyloxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-tetracos-13-enoate

[2-[(Z)-docos-13-enoyl]oxy-3-tetradecanoyloxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-octacos-17-enoate

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] triacontanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

[2-hexadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

[2-hexadecanoyloxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[3-dodecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] triacontanoate

[3-dodecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] nonacosanoate

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

(2-octadecanoyloxy-3-tetradecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(2-octadecanoyloxy-3-tetradecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[3-decanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] hexacosanoate

[3-decanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] triacontanoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] triacontanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] triacontanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propyl dotriacontanoate

2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propyl dotriacontanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecanoyloxypropyl] heptacosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-tridecanoyloxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] octacosanoate

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] heptacosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] octacosanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-tetradecanoyloxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

(3-decanoyloxy-2-icosanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

(3-decanoyloxy-2-icosanoyloxypropyl) (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-icosanoyloxypropyl] tricosanoate

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-icosanoyloxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] tricosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-nonadecanoyloxypropyl] tetracosanoate

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-nonadecanoyloxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[3-heptadecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] tricosanoate

[3-heptadecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] tetracosanoate

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] pentacosanoate

[3-hexadecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-nonadecanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

(2-icosanoyloxy-3-nonadecanoyloxypropyl) (11Z,14Z)-henicosa-11,14-dienoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-nonadecanoyloxypropyl] pentacosanoate

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-nonadecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hexadecanoyloxypropyl] tricosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hexadecanoyloxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

2,3-di(octadecanoyloxy)propyl (13Z,16Z)-tetracosa-13,16-dienoate

2,3-di(octadecanoyloxy)propyl (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[3-[(Z)-hexadec-9-enoyl]oxy-2-octadecanoyloxypropyl] (Z)-hexacos-15-enoate

[3-[(Z)-hexadec-9-enoyl]oxy-2-octadecanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] tetracosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] docosanoate

[2-henicosanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] pentacosanoate

[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-heptadecanoyloxypropyl] docosanoate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-heptadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

(2-nonadecanoyloxy-3-pentadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(2-nonadecanoyloxy-3-pentadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] pentacosanoate

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] tetracosanoate

[3-hexadecanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

2,3-di(hexadecanoyloxy)propyl (17Z,20Z)-octacosa-17,20-dienoate

2,3-di(hexadecanoyloxy)propyl (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[3-hexadecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] pentacosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] tricosanoate

[2-henicosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] hexacosanoate

[3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] tetracosanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-octadecanoyloxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-heptadecanoyloxypropyl] hexacosanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-heptadecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[3-heptadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[3-heptadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonadecanoyloxypropyl] docosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

[2-icosanoyloxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-henicos-11-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] octacosanoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] henicosanoate

[2-icosanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

[2-nonadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tricosanoate

[2-nonadecanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] pentacosanoate

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-heptadec-9-enoyl]oxy]propyl hexacosanoate

2,3-bis[[(Z)-heptadec-9-enoyl]oxy]propyl hexacosanoate

C63H118O6 (970.8927928)


   

[3-heptadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] pentacosanoate

[3-heptadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-octacos-17-enoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] octacosanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] heptacosanoate

[2-[(Z)-octadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] tricosanoate

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-icos-11-enoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] octacosanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] octacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] heptacosanoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hexadecanoyloxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

(3-hexadecanoyloxy-2-icosanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

(3-hexadecanoyloxy-2-icosanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] heptacosanoate

[2-[(Z)-heptadec-9-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] tricosanoate

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-hexadec-9-enoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

(3-hexadecanoyloxy-2-octadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

(3-hexadecanoyloxy-2-octadecanoyloxypropyl) (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-heptadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

(2-henicosanoyloxy-3-heptadecanoyloxypropyl) (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] tricosanoate

[2-[(Z)-docos-13-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

[2-nonadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[2-nonadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-pentadec-9-enoyl]oxy]propyl triacontanoate

2,3-bis[[(Z)-pentadec-9-enoyl]oxy]propyl triacontanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[2-henicosanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecanoyloxypropyl] (Z)-docos-13-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-heptadecanoyloxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] pentacosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-pentadecanoyloxypropyl] pentacosanoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] hexacosanoate

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-octadecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] hexacosanoate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

(2-heptadecanoyloxy-3-pentadecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

(2-heptadecanoyloxy-3-pentadecanoyloxypropyl) (17Z,20Z)-octacosa-17,20-dienoate

C63H118O6 (970.8927928)


   

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] tetracosanoate

[3-[(Z)-heptadec-9-enoyl]oxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[3-[(Z)-hexadec-9-enoyl]oxy-2-icosanoyloxypropyl] (Z)-tetracos-13-enoate

[3-[(Z)-hexadec-9-enoyl]oxy-2-icosanoyloxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] hexacosanoate

[3-[(Z)-hexadec-9-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] hexacosanoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] docosanoate

[2-icosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] nonacosanoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

[2-henicosanoyloxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-docos-13-enoate

C63H118O6 (970.8927928)


   

[3-hexadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

[3-hexadecanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-henicos-11-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-henicos-11-enoate

C63H118O6 (970.8927928)


   

[3-octadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

[3-octadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[3-[(Z)-heptadec-9-enoyl]oxy-2-nonadecanoyloxypropyl] (Z)-tetracos-13-enoate

[3-[(Z)-heptadec-9-enoyl]oxy-2-nonadecanoyloxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

[3-pentadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-triacont-19-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-tetracos-13-enoate

[2-[(Z)-henicos-11-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-tetracos-13-enoate

C63H118O6 (970.8927928)


   

[1-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] henicosanoate

[1-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropan-2-yl] henicosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] heptacosanoate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] nonacosanoate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-pentadecanoyloxypropyl] nonacosanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-hexadec-9-enoyl]oxy]propyl octacosanoate

2,3-bis[[(Z)-hexadec-9-enoyl]oxy]propyl octacosanoate

C63H118O6 (970.8927928)


   

2,3-di(heptadecanoyloxy)propyl (15Z,18Z)-hexacosa-15,18-dienoate

2,3-di(heptadecanoyloxy)propyl (15Z,18Z)-hexacosa-15,18-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-hexacos-15-enoate

[2-[(Z)-nonadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

2,3-di(pentadecanoyloxy)propyl (19Z,22Z)-triaconta-19,22-dienoate

2,3-di(pentadecanoyloxy)propyl (19Z,22Z)-triaconta-19,22-dienoate

C63H118O6 (970.8927928)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-icosanoyloxypropyl] tetracosanoate

[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-icosanoyloxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-nonadecanoyloxypropyl] (Z)-henicos-11-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-nonadecanoyloxypropyl] (Z)-henicos-11-enoate

C63H118O6 (970.8927928)


   

[2-heptadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

[2-heptadecanoyloxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (Z)-octacos-17-enoate

C63H118O6 (970.8927928)


   

[2-docosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] docosanoate

[2-docosanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octadecanoyloxypropan-2-yl] henicosanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octadecanoyloxypropan-2-yl] henicosanoate

C63H118O6 (970.8927928)


   

2,3-di(nonadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

2,3-di(nonadecanoyloxy)propyl (13Z,16Z)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[3-heptadecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] tetracosanoate

[3-heptadecanoyloxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] tetracosanoate

C63H118O6 (970.8927928)


   

[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] heptacosanoate

[2-heptadecanoyloxy-3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] heptacosanoate

C63H118O6 (970.8927928)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-pentadecanoyloxypropyl] tricosanoate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-pentadecanoyloxypropyl] tricosanoate

C63H118O6 (970.8927928)


   

(3-heptadecanoyloxy-2-nonadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

(3-heptadecanoyloxy-2-nonadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] docosanoate

[2-[(Z)-henicos-11-enoyl]oxy-3-[(Z)-heptadec-9-enoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

[3-heptadecanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] (Z)-hexacos-15-enoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate

[2-henicosanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-pentadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

(2-henicosanoyloxy-3-pentadecanoyloxypropyl) (13Z,16Z)-tetracosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[3-Hydroxy-2-(tetratetracontanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tetratetracontanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tetracosanoylamino)nonacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tetracosanoylamino)nonacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Dotriacontanoylamino)-3-hydroxyhenicosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Dotriacontanoylamino)-3-hydroxyhenicosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Hentriacontanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hentriacontanoylamino)-3-hydroxydocosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(pentacosanoylamino)octacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentacosanoylamino)octacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(pentatriacontanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(pentatriacontanoylamino)octadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tritriacontanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tritriacontanoylamino)icosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(octacosanoylamino)pentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octacosanoylamino)pentacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tetratriacontanoylamino)nonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tetratriacontanoylamino)nonadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(octatriacontanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(octatriacontanoylamino)pentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Heptacosanoylamino)-3-hydroxyhexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Heptacosanoylamino)-3-hydroxyhexacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(tricosanoylamino)triacontyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(tricosanoylamino)triacontyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(triacontanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(triacontanoylamino)tricosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Hexatriacontanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexatriacontanoylamino)-3-hydroxyheptadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-Hydroxy-2-(nonacosanoylamino)tetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-Hydroxy-2-(nonacosanoylamino)tetracosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[2-(Hexacosanoylamino)-3-hydroxyheptacosyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-(Hexacosanoylamino)-3-hydroxyheptacosyl] 2-(trimethylazaniumyl)ethyl phosphate

C58H119N2O6P (970.8805284)


   

[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-icosanoyloxypropyl] icosanoate

[3-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-2-icosanoyloxypropyl] icosanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-nonadec-9-enoyl]oxy]propyl docosanoate

2,3-bis[[(Z)-nonadec-9-enoyl]oxy]propyl docosanoate

C63H118O6 (970.8927928)


   

2,3-bis[[(Z)-icos-11-enoyl]oxy]propyl icosanoate

2,3-bis[[(Z)-icos-11-enoyl]oxy]propyl icosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] henicosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octadecanoyloxypropyl] docosanoate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropyl] docosanoate

[2-[(Z)-icos-11-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[1-[(Z)-docos-11-enoyl]oxy-3-[(Z)-hexadec-7-enoyl]oxypropan-2-yl] docosanoate

[1-[(Z)-docos-11-enoyl]oxy-3-[(Z)-hexadec-7-enoyl]oxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

(2-henicosanoyloxy-3-heptadecanoyloxypropyl) (14Z,16Z)-docosa-14,16-dienoate

(2-henicosanoyloxy-3-heptadecanoyloxypropyl) (14Z,16Z)-docosa-14,16-dienoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(Z)-octadec-11-enoyl]oxypropyl] (Z)-docos-11-enoate

[2-icosanoyloxy-3-[(Z)-octadec-11-enoyl]oxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(10Z,12Z)-octadeca-10,12-dienoyl]oxypropyl] docosanoate

[2-icosanoyloxy-3-[(10Z,12Z)-octadeca-10,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[1-[(14Z,16Z)-docosa-14,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

[1-[(14Z,16Z)-docosa-14,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-nonadecanoyloxypropyl] (Z)-henicos-9-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-nonadecanoyloxypropyl] (Z)-henicos-9-enoate

C63H118O6 (970.8927928)


   

[2-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxy-3-nonadecanoyloxypropyl] docosanoate

[2-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxy-3-nonadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-docos-11-enoate

[2-[(Z)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-henicos-9-enoate

[2-icosanoyloxy-3-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-henicos-9-enoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-nonadecanoyloxypropyl) (9Z,11Z)-henicosa-9,11-dienoate

(2-icosanoyloxy-3-nonadecanoyloxypropyl) (9Z,11Z)-henicosa-9,11-dienoate

C63H118O6 (970.8927928)


   

[2-icosanoyloxy-3-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxypropyl] henicosanoate

[2-icosanoyloxy-3-[(7Z,9Z)-nonadeca-7,9-dienoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-docos-11-enoate

[3-nonadecanoyloxy-2-[(Z)-nonadec-9-enoyl]oxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-9-enoyl]oxy-3-[(Z)-heptadec-7-enoyl]oxypropyl] docosanoate

[2-[(Z)-henicos-9-enoyl]oxy-3-[(Z)-heptadec-7-enoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-9-enoyl]oxy-3-heptadecanoyloxypropyl] (Z)-docos-11-enoate

[2-[(Z)-henicos-9-enoyl]oxy-3-heptadecanoyloxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(Z)-heptadec-7-enoyl]oxypropyl] (Z)-docos-11-enoate

[2-henicosanoyloxy-3-[(Z)-heptadec-7-enoyl]oxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-henicos-9-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-henicos-9-enoate

[2-[(Z)-henicos-9-enoyl]oxy-3-octadecanoyloxypropyl] (Z)-henicos-9-enoate

C63H118O6 (970.8927928)


   

[2-[(Z)-docos-11-enoyl]oxy-3-hexadecanoyloxypropyl] (Z)-docos-11-enoate

[2-[(Z)-docos-11-enoyl]oxy-3-hexadecanoyloxypropyl] (Z)-docos-11-enoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(10Z,12Z)-octadeca-10,12-dienoyl]oxypropyl] henicosanoate

[2-henicosanoyloxy-3-[(10Z,12Z)-octadeca-10,12-dienoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

[2-henicosanoyloxy-3-[(11Z,14Z)-heptadeca-11,14-dienoyl]oxypropyl] docosanoate

[2-henicosanoyloxy-3-[(11Z,14Z)-heptadeca-11,14-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[1-[(9Z,11Z)-henicosa-9,11-dienoyl]oxy-3-octadecanoyloxypropan-2-yl] henicosanoate

[1-[(9Z,11Z)-henicosa-9,11-dienoyl]oxy-3-octadecanoyloxypropan-2-yl] henicosanoate

C63H118O6 (970.8927928)


   

[2-docosanoyloxy-3-[(4Z,7Z)-hexadeca-4,7-dienoyl]oxypropyl] docosanoate

[2-docosanoyloxy-3-[(4Z,7Z)-hexadeca-4,7-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

2,3-di(nonadecanoyloxy)propyl (14Z,16Z)-docosa-14,16-dienoate

2,3-di(nonadecanoyloxy)propyl (14Z,16Z)-docosa-14,16-dienoate

C63H118O6 (970.8927928)


   

[2-[(9Z,11Z)-henicosa-9,11-dienoyl]oxy-3-heptadecanoyloxypropyl] docosanoate

[2-[(9Z,11Z)-henicosa-9,11-dienoyl]oxy-3-heptadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

(2-icosanoyloxy-3-octadecanoyloxypropyl) (14Z,16Z)-docosa-14,16-dienoate

(2-icosanoyloxy-3-octadecanoyloxypropyl) (14Z,16Z)-docosa-14,16-dienoate

C63H118O6 (970.8927928)


   

[1-[(Z)-henicos-9-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropan-2-yl] henicosanoate

[1-[(Z)-henicos-9-enoyl]oxy-3-[(Z)-octadec-11-enoyl]oxypropan-2-yl] henicosanoate

C63H118O6 (970.8927928)


   

[(2S)-2-icosanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] (E)-docos-13-enoate

[(2S)-2-icosanoyloxy-3-[(E)-octadec-11-enoyl]oxypropyl] (E)-docos-13-enoate

C63H118O6 (970.8927928)


   

[(2S)-2-[(E)-icos-11-enoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] docosanoate

[(2S)-2-[(E)-icos-11-enoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[(2S)-2-henicosanoyloxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] docosanoate

[(2S)-2-henicosanoyloxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[(2S)-1-[(E)-docos-13-enoyl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] docosanoate

[(2S)-1-[(E)-docos-13-enoyl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

[(2R)-2-icosanoyloxy-3-octadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

[(2R)-2-icosanoyloxy-3-octadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-icosanoyloxypropyl] icosanoate

[(2R)-3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-icosanoyloxypropyl] icosanoate

C63H118O6 (970.8927928)


   

[(2R)-2-henicosanoyloxy-3-heptadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

[(2R)-2-henicosanoyloxy-3-heptadecanoyloxypropyl] (13E,16E)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (E)-docos-13-enoate

[(2R)-2-[(E)-icos-11-enoyl]oxy-3-octadecanoyloxypropyl] (E)-docos-13-enoate

C63H118O6 (970.8927928)


   

[(2S)-2-icosanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] docosanoate

[(2S)-2-icosanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-nonadecanoyloxypropyl] henicosanoate

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-nonadecanoyloxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

[(2S)-2-henicosanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] (E)-docos-13-enoate

[(2S)-2-henicosanoyloxy-3-[(E)-heptadec-9-enoyl]oxypropyl] (E)-docos-13-enoate

C63H118O6 (970.8927928)


   

[(2R)-2,3-bis[[(E)-icos-11-enoyl]oxy]propyl] icosanoate

[(2R)-2,3-bis[[(E)-icos-11-enoyl]oxy]propyl] icosanoate

C63H118O6 (970.8927928)


   

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] (E)-docos-13-enoate

[(2R)-2-[(E)-docos-13-enoyl]oxy-3-hexadecanoyloxypropyl] (E)-docos-13-enoate

C63H118O6 (970.8927928)


   

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-octadecanoyloxypropyl] docosanoate

[(2R)-2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-octadecanoyloxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[(2R)-1-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

[(2R)-1-[(13E,16E)-docosa-13,16-dienoyl]oxy-3-hexadecanoyloxypropan-2-yl] docosanoate

C63H118O6 (970.8927928)


   

[2-docosanoyloxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] docosanoate

[2-docosanoyloxy-3-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] docosanoate

C63H118O6 (970.8927928)


   

[(2R)-2,3-di(nonadecanoyloxy)propyl] (13E,16E)-docosa-13,16-dienoate

[(2R)-2,3-di(nonadecanoyloxy)propyl] (13E,16E)-docosa-13,16-dienoate

C63H118O6 (970.8927928)


   

[(2S)-2-henicosanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate

[(2S)-2-henicosanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] henicosanoate

C63H118O6 (970.8927928)


   

1-eicosanoyl-2,3-di-(11Z-eicosenoyl)-sn-glycerol

1-eicosanoyl-2,3-di-(11Z-eicosenoyl)-sn-glycerol

C63H118O6 (970.8927928)